Re: What's the deal with Zenith?
in response to
by
posted on
Jun 24, 2023 04:57PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
NBB ... I can ride with that approach. And I totally get the skepticism, from all. I am not exactly looking at Ferrari's with anticipation, and holding my breath. Just happy to hear a new idea, that incorporates the big picture, and involves both companies, and a BP, whether this inspiration is the ticket or not (doubtful) ... again, my "want" is for this BoD crew to be creative, and work toward a BoM2 financing solution, and get things moving again and advancing. The discussion road, once the journey begins, can have twists & turns.
Honestly, if it isn't a bunch of crap, the Morocco/M.E. initiative has more and sooner promise. If they can get EUA over there, and some bulk sales, maybe that gets financing & other things going also. Or it all looks promising enough to attract other buyers/investors/funding in a non-dilutive way, which is a challenge.
Still curious, why it is crickets in China and other parts of Asia, given some connections.